Group items tagged

Torrence Hatch Jr charges with drug possession and Murder for 4 years In 2009, Hatch was sentenced to 4 years in prison on drug and gun charges. In 2010, he was indicted on first-degree murder charges and was also sentenced to 10 years on multiple charges of drug possession with intent of distribution... #news #singer #trendbuddies #torrence #hatchjrchanrges #drugpossession #murder #fouryears #spoiler #alert #spoliernews #alertnews #breaingnews #guncharges https://trendbuddies.com/torrence-hatch-jr-charges/

Erectile Dysfunction Drugs Market Size - Industry Trends Report, 2026

Erectile Dysfunction Drugs Market

Erectile Dysfunction Drugs Market Size - Industry Trends Report, 2026

The worldwide Glaucoma Drugs Market is conscientiously looked into inside the report while generally focusing on top players and their business strategies, topographical development, advertise sections, serious scene, assembling, and evaluating and value structures. Each area of the examination study is extraordinarily arranged to investigate key parts of the overall Glaucoma Drugs Market. for instance…

Global Migraine Drugs Market Size, Share, Trends - Industry Report 2025

Global Migraine Drugs Market Size, Share, Trends - Industry Report 2025

Global Migraine Drugs Market Size, Share, Trends - Industry Report 2025

Intravenous Iron Drugs Market Share, Size, Trends, Industry Analysis Report, By Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, Others), By Products (Iron Dextran, Iron Sucrose, Ferric Carboxymaltose, Others), By Region; Segment Forecast, 2021 - 2028

The US Food and Drug Administration (USFDA) has restricted imports of drugs from Pune-based Badrivishal Chemicals & Pharmaceutic

Active pharmaceutical ingredient (API) is a biologically active pharmaceutical drug. API can be obtained by a synthetic process or from natural sources. The increasing occurrence of chronic diseases, rising acceptance, and uptake of pharmaceuticals, growth in abbreviated new drug applications (ANDA), and the growing importance of generics are expected to drive market growth. For instance, according to the report published by the Centers for Disease Control and Prevention (CDC), nearly 92.1 million adults in the US dealt with at least one type of cardiovascular diseases in 2017. However, stringent regulatory policies and adverse drug price control policies across numerous countries may hamper the growth of the market.

"The global acromegaly treatment market size is expected to reach USD 2.10 billion by 2025. It is anticipated to register a CAGR of 7.5% over the forecast period. Increasing incidence of the acromegaly disease is expected to drive the growth. For instance, the disease prevalence increased fourfold in 2015 from its previous year 2014, according to a report by the Endocrine Society. Moreover, growing investment in clinical trials by various pharmaceutical companies to develop new molecules is another factor propelling the market growth. Furthermore, strong pipeline of drugs is anticipated to create growth opportunities in the forthcoming years. For instance, Mycapssa by Chiasma Inc. received approval in Europe in 2016. In 2018, Antisense Therapeutics launched their new formulation ALT1103 in U.S. ISIS 766720 by Ionis Pharmaceuticals Inc., a growth hormone receptor antagonist is currently under phase II clinical trial and is expected to be finished by December 2019. The strong pipeline of drugs for somatostatin analogs is expected to propel growth of the acromegaly treatment market in near future. For instance, in 2018 around 30 clinical trials were being conducted in North America and many are waiting for the U.S. Food and Drug Administration (FDA) approval."

This is a quick update to let you know that the Ministry of Health and Family Welfare ("Ministry") has notified the list of devices intended for use in human beings as drugs in line with the Drugs and Cosmetics Act, 1940.

Human Immunodeficiency Virus (HIV) Drugs Market is projected to have highest share from 2017-2025 according to a new report published by Polaris Market

Human Immunodeficiency Virus (

Global Human Immunodeficiency Virus (HIV) Drugs Market Size 2025

Global Diabetes Drug Market Size, Share - Industry Trends Report 2025

Specialty Generic Drugs Market

Specialty Generic Drugs Market Size to Reach $190.9 Billion by 2025

Platinum Based Cancer Drugs Market Size - Global Industry Report, 2019-2026

The global Platinum Based Cancer Drugs market was valued at USD 1310.3 Million in 2018 and is expected to exhibit a CAGR of 4.1% over the forecast period.

The global antipsychotic drugs market was valued at USD 13 billion in 2019 and is expected to reach USD 15 billion by 2026, expanding at a CAGR of around 4 % during the forecast period, 2020 - 2026. The demand for antipsychotic drugs is being driven by the growing prevalence of psychosis related diseases. Genetic mutations, physical illness, and substance-induced psychoses resulting in depression are the major factors contributing towards the growing incidence of psychosis related disorders. Huge R&D investments and launching if new antipsychotic compounds are fueling the market growth. To expand therapeutic applications of medicines, increasing efforts are taken by the market players which is estimated to create new opportunities for antipsychotic drugs market during the forecast period, thereby contributing to the growth of the market.

Orphan Drugs Market Size, Share, Trends - Global Industry Report 2025

Orphan Drugs Market Size, Share, Trends - Global Industry Report 2025

Hypertension Drug Market Size, Share - Industry Trends Report, 2025

Hypertension Drug Market Size, Share - Industry Trends Report, 2025

Global AI in Drug Discovery Market Size Worth $4.05 Billion By 2028

Global AI in Drug Discovery Market

Closed System Drug Transfer Device Market Size Worth $1.91 Billion By 2028 | CAGR: 20.1%: Polaris Market Research | Medgadget

Closed System Drug Transfer Device Market Size Worth $1.91 Billion By 2028 | CAGR: 20.1%: Polaris Market Research | Medgadget

Reports & Insights has freshly issued a new report titled "Cannabis Market: Opportunity Analysis and Future Assessment 2022-2030" which speaks about the market size, market potential and comprehensive understanding of the statistics concerned with the development of the respective market. The market analysts estimate that the Cannabis Market size will elevate from 28.1 Bn in 2022 to 197.5 Bn by the year 2030, at an estimated CAGR of 27.6%. The base year considered for the study is 2020, and the market size is projected from 2022 to 2030. The cannabis market is estimated to reach at a value of US$ 28.1 Bn by the end of 2022 and expected to reach at a value of US$ 197.5 Bn by 2030 with a significant CAGR of 27.6%. Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/8265 Cannabis Introduction Cannabis sativa L. (Cannabaceae) is one of the earliest medicinal plants utilized by humans. Basically, Cannabis is the preferable identification name of the plant Cannabis indica, Cannabis sativa, and of minor significance, Cannabis ruderalis. For thousands of years, the plant has served its utility for mankind for oil and fiber production, and simply as a supplement for different food items. Cannabis is the world's most ordinarily cultivated, smuggled, and used as unauthorized and illegal drug, and in addition to that, as the encouragement for legalization of cultivation of cannabis at home and abroad is surging, cannabis or marijuana is gaining significant attention from manufacturers, investors, and researchers across the world. Moreover, cannabis is considered to contain a variety of medicinally essential compounds such as, terpenoids, cannabinoids, alkaloids, flavonoids, and others, which further escalates its applications in medicinal uses in the healthcare sector. Cannabis, which was once considered an unauthorized and illegal substance is believed a restricted and governed drug within several government guidelines in presen

The recently published report titled, "Botanical Extracts Market: Opportunity Analysis and Future Assessment 2022-2030" in the database of the Reports and Insights be of assistance to a paradigm solution for clearer and greater understanding of the market. It is beneficial in determining the size of the market for particular products. These leading players functioning in this market are in rigorous competition in terms of innovation, technology, product pricing and product development. Moreover, the market study helps in establishing sales prophecies for its products and therefore, creating symmetrical adjustment between demand and supply of its products. In 2021, the U.S. botanical extracts market was valued at US$ 1,288.7 Mn and is estimated to reach at a value of US$ 1,470.5 Mn by the end of 2022, with a growth rate of 6.6% Request a Sample Copy of this Report @:https://reportsandinsights.com/sample-request/1391 Botanical Extracts Introduction Botany refers to another domain of biology that copes with the analysis of plants, comprising their composition, attributes, and biochemical procedures. It further involves plant categorization and the scrutiny of plant illness and of synergies with the environment. Similarly, botanical extracts can be comprehended as the plant-based products that are used for its remedial or medicinal properties, scent, and/or flavor. The plant-based extracts are basically derived from the plants, precisely from its barks, roots, leaves, stems, flowers and fruits. As a matter of fact, these botanical extracts are serving great utility in the pharmaceutical as well as cosmetic industry in recent times, owing to their therapeutic properties. Botanical Extracts Market Dynamics The expeditiously growing demand of botanical extracts in the cosmetics as well as pharmaceutical industries all across the world is one of the major factors that is projected to boost the growth of the global botanical extracts market in the years to come.